Pharmacoeconomics. 2024 May 8. doi: 10.1007/s40273-024-01394-8. Online ahead of print.
NO ABSTRACT
PMID:38717708 | DOI:10.1007/s40273-024-01394-8
Categories
Challenges in the Assessment of a Disease Model in the NICE Single Technology Appraisal of Tirzepatide for Treating Type 2 Diabetes: An External Assessment Group Perspective
